Clinical Trial Update: Sex-Mismatched Allogeneic Bone Marrow Transplantation for Men With Metastatic Castration-Resistant Prostate Cancer [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating sex-mismatched allogeneic bone marrow transplantation in men with metastatic castration-resistant prostate cancer; study termi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• sex-mismatched allogeneic bone marrow transplantation (allogeneic bone marrow transplantation)

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Conditions: Prostate Cancer | Phase 1 | Status: TERMINATED | Results posted: 2024-02-13